Calcium channel blockers are independently associated with short sleep duration in hypertensive patients with obstructive sleep apnea

Journal of Hypertension

Volumn 29, Issue 6, 2011, Pages 1236-1241

  Nerbass, Flávia B ^a   Pedrosa, Rodrigo P ^a   Genta, Pedro R ^a   Drager, Luciano F ^a   Lorenzi Filho, Geraldo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

antihypertensive medication; calcium channel blockers; hypertension; obstructive sleep apnea; short sleep duration

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

APNEA HYPOPNEA INDEX; ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP PARAMETERS; SLEEP PATTERN; SLEEP TIME;

EID: 79955585373     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283462e8b     Document Type: Article

References (37)

1. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of the American Academy of Sleep Medicine Task Force. Sleep 1999; 22:667-689.
2. Lavie P, Lavie L. Cardiovascular morbidity and mortality in obstructive sleep apnea. Curr Pharm Des 2008; 14:3466-3473.
3. Wang H, Parker JD, Newton GE, Floras JS, Mak S, Chiu KL, et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007; 49:1625-1631. (Pubitemid 46551635)
4. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et al. Association between sleep-disordered breathing, sleep apnea and hypertension in a large community-based study. JAMA 2000; 283:1829-1836. (Pubitemid 30207619)
5. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342:1378-1384. (Pubitemid 30262394)
6. Drager LF, Pereira AC, Barreto-Filho JA, Figueiredo AC, Krieger JE, Krieger EM, Lorenzi-Filho G. Phenotypic characteristics associated with hypertension in patients with obstructive sleep apnea. J Hum Hypertens 2006; 20:523-528. (Pubitemid 43923123)
7. Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001; 19:2271-2277. (Pubitemid 33135251)
8. Drager LF, Bortolotto LA, Figueiredo AC, Silva BC, Krieger EM, Lorenzi- Filho G. Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest 2007; 131:1379-1386. (Pubitemid 46762342)
9. Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, Pickering TG, et al. Short sleep duration as a risk factor for hypertension: analyses of the First National Health and Nutrition Examination Survey. Hypertension 2006; 47:833-839. (Pubitemid 44297552)
10. Gottieb DJ, Redline S, Nieto FJ, Baldwin CM, Newman AB, Resnick HE, Punjabi NM. Association of usual sleep duration with hypertension: The Sleep Heart Health Study. Sleep 2006; 29:1009-1014. (Pubitemid 44257377)
11. Knutson KL, Cauter EV, Rathouz PJ, Yan LL, Hulley SB, Liu K, Lauderdale DS. Association between sleep and blood pressure in midlife: The Cardia Sleep Study. Arch Intern Med 2009; 169:1055-1061.
12. Eguchi K, Pickering TG, Schwartz JE, Hoshide S, Ishikawa J, Ishikawa S, et al. Short sleep duration as an independent predictor of cardiovascular events in Japanese patients with hypertension. Arch Intern Med 2008; 168:2225-2231.
13. Belcaro G, Cesarone MR, Ricci A, Cornelli U, Rodhewald P, Ledda A, et al. Control of edema in hypertensive subjects treated with calcium antagonist (nifedipine) or angiotensin-converting enzyme inhibitors with Pycnogenol. Clin Appl Thromb Hemost 2006; 12:440-444. (Pubitemid 44359241)
14. Andrésdó ttir MB, van Hamersvelt HW, van Helden MJ, van de Bosch WJ, Valk IM, Huysmans FT. Ankle edema formation during treatment with the calcium channel blockers lacidipine and amlodipine: a single-centre study. J Cardiovasc Pharmacol 2000; 35 (3 Suppl 1):S25-S30.
15. Pedrinelli R, Dell'Omo G, Melillo E, Mariani M. Amlodipine, enalapril, and dependent leg edema in essential hypertension. Hypertension 2000; 35:621-625. (Pubitemid 30108158)
16. Simonneau G, Escourrou P, Duroux P, Lockhart A. Inhibition of a hypoxic pulmonary vasoconstriction by nifedipine. N Engl J Med 1981; 304:1582-1585. (Pubitemid 11122507)
17. Ruttanaumpawan P, Nopmaneejumruslers C, Logan AG, Lazarescu A, Quian I, Bradley TD. Association between refractory hypertension and obstructive sleep apnea. J Hypertens 2009; 27:1439-1445.
18. Kostis JB, Rosen RC. Central nervous system effects of beta-adrenergicblocking drugs: the role of ancillary properties. Circulation 1987; 75:204-212. (Pubitemid 17234559)
19. Ongini E, Milani S, Marzanatti M, Trampus M, Monopoli A. Effects of selected Beta-adrenergic blocking agents on sleep stages in spontaneously hypertensive rats. J Pharmacol Exp Ther 1990; 257:114-119.
20. Monti JM. Disturbances of sleep and wakefulness associated with the use of antihypertensive agents. Life Science 1987; 41:1979-1988. (Pubitemid 18006126)
21. Iber C, Ancoli-Israel S, Chesson AL, Quan SF, for the American Academy of Sleep Medicine. The AASM manual for scoring of sleep associated events: rules, terminology and technical specifications. Wetchester, IL: American Academy of Sleep Medicine; 2007.
22. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252. (Pubitemid 37553153)
23. Balaguer C, Palou A, Alonso-Fernández A. Smoking and sleep disorders. Arch Bronconeumol 2009; 45:449-458.
24. Barone MT, Menna-Barreto L. Diabetes and sleep: a complex cause-and-effect relationship. Diabetes Res Clin Pract 2010 [Epub ahead of print].
25. Lorenzi-Filho G, Genta PR, Figueiredo AC, Inoue D. Cheyne-Stokes respiration in patients with congestive heart failure: causes and consequences. Clinics (Sao Paulo). 2005; 60:333-344 [Review].
26. Drager LF, Bortolotto LA, Lorenzi MC, Figueiredo AC, Krieger EM, Lorenzi-Filho G. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2005; 172:613-618. (Pubitemid 41232973)
27. Vgontzas AN, Liao D, Bixler EO, Chrousos GP, Vela-Bueno A. Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep 2009; 32:491-497.
28. Eguchi K, Hoshide S, Ishikawa S, Shimada K, Kario K. Short sleep duration is an independent predictor of stroke events in elderly hypertensive patients. J Am Soc Hypertens 2010; 4:255-262.
29. Issa FG. Effect of clonidine in obstructive sleep apnea. Am Rev Respir Dis 1992; 145 (2 Pt 1):435-439.
30. Mayer J, Weichler U, Herres-Mayer B, Schneider H, Marx U, Peter JH. Influence of metoprolol and cilazapril on blood pressure and on sleep apnea activity. J Cardiovasc Pharmacol 1990; 16:952-961.
31. Kraiczi H, Hedner J, Peker Y, Grote L. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2000; 161:1423-1428. (Pubitemid 30329007)
32. Kennedy T, Summer W. Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. Am J Cardiol 1982; 50:864-868. (Pubitemid 12028313)
33. Redolfi S, Yumino D, Ruttanaumpawan P, Yau B, Su MC, Lam J, Bradley TD. Relationship between overnight rostral fluid shift and obstructive sleep apnea in nonobese men. Am J Respir Crit Care Med 2009; 179:241-246.
34. Chiu KL, Ryan CM, Shiota S, Ruttanaumpawan P, Arzt M, Haight JS, et al. Fluid shift by lower body positive pressure increases pharyngeal resistance in healthy subjects. Am J Respir Crit Care Med 2006; 174:1378-1383. (Pubitemid 44913040)
35. Friedman O, Bradley DT, Ruttanaumpawan P, Logan AG. Independent association of drug-resistant hypertension to reduced sleep duration and efficiency. Am J Hypertens 2010; 23:174-179.
36. Zhong X, Hilton HJ, Gates GJ, Jelic S, Stern Y, Bartels MN, et al. Increased sympathetic and decreased parasympathetic cardiovascular modulation in normal humans with acute sleep deprivation. J Appl Physiol 2005; 98:2024-2032. (Pubitemid 40726893)
37. Tochikubo O, Ikeda A, Miyajima E, Ishii M. Effects of insufficient sleep on blood pressure monitored by a new multibiomedical recorder. Hypertension 1996; 27:1318-1324. (Pubitemid 26165637)